Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype

Psychiatry Research

Volumn 177, Issue 3, 2010, Pages 354-357

  Hinkelmann, Kim ^a   Dragoi, Laura ^a   Gompf, Julia ^a   Muhtz, Christoph ^a   Demiralay, Cüneyt ^a   Yassouridis, Alexander ^b   Wiedemann, Klaus ^a   Kellner, Michael ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

5 HTTLPR; Affective perception; Emotion; Facial recognition; Information processing; SSRI

Indexed keywords

ESCITALOPRAM; PLACEBO; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

AFFECT; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EMOTIONALITY; FACIAL EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; TASK PERFORMANCE;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; POLYMORPHISM, GENETIC; RECOGNITION (PSYCHOLOGY); SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 77952672404     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.03.008     Document Type: Article

References (26)

1. Anderson I.M., Del-Ben C.M., McKie S., Richardson P., Williams S.R., Elliott R., Deakin J.F. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport 2007, 18(13):1351-1355.
2. Arce E., Simmons A.N., Lovero K.L., Stein M.B., Paulus M.P. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 2008, 196(4):661-672.
3. Arias B., Catalan R., Gasto C., Gutierrez B., Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. Journal of Clinical Psychopharmacology 2003, 23(6):563-567.
4. Barr L.C., Heninger G.R., Goodman W., Charney D.S., Price L.H. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biological Psychiatry 1997, 41(9):949-954.
5. Bigos K.L., Pollock B.G., Aizenstein H.J., Fisher P.M., Bies R.R., Hariri A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33(13):3221-3225.
6. Browning M., Reid C., Cowen P.J., Goodwin G.M., Harmer C.J. A single dose of citalopram increases fear recognition in healthy subjects. Journal of Psychopharmacology 2007, 21(7):684-690.
7. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301(5631):386-389.
8. Del-Ben C.M., Deakin J.F., McKie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 2005, 30(9):1724-1734.
9. Ekman P., Friesen W.V. Pictures of Facial Affect 1976, Consulting Psychologists Press, Palo Alto, CA.
10. Frazer A., Benmansour S. Delayed pharmacological effects of antidepressants. Molecular Psychiatry 2002, 7(1):23-28.
11. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., Andrew C.M., Pich E.M., Williams P.M., Reed L.J., Mitterschiffthaler M.T., Suckling J., Bullmore E.T. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 2004, 61(9):877-889.
12. Gelfin Y., Gorfine M., Lerer B. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. American Journal of Psychiatry 1998, 155(2):290-292.
13. Harmer C.J., Bhagwagar Z., Perrett D.I., Vollm B.A., Cowen P.J., Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003, 28(1):148-152.
14. Harmer C.J., Hill S.A., Taylor M.J., Cowen P.J., Goodwin G.M. Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. American Journal of Psychiatry 2003, 160(5):990-992.
15. Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry 2004, 161(7):1256-1263.
16. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry 2006, 59(9):816-820.
17. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 2009, 195(2):102-108.
18. Izard C.E., Libero D.Z., Putnam P., Haynes O.M. Stability of emotion experiences and their relations to traits of personality. Journal of Personality and Social Psychology 1993, 64(5):847-860.
19. Kellner M., Demiralay C., Muhtz C., Husemann J., Kolsch W., Hiemke C., Yassouridis A., Wiedemann K. No effect of six weeks of treatment with escitalopram on mood in healthy volunteers - irrespective of genotype for the promoter of the serotonin transporter. Psychiatry Research 2008, 161(3):339-343.
20. Kemp A.H., Gray M.A., Silberstein R.B., Armstrong S.M., Nathan P.J. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage 2004, 22(3):1084-1096.
21. Lang P.J., Greenwald M.K., Bradley M.M., Hamm A.O. Looking at pictures: affective, facial, visceral, and behavioral reactions. Psychophysiology 1993, 30(3):261-273.
22. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
23. Murphy S.E., Norbury R., O'Sullivan U., Cowen P.J., Harmer C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. British Journal of Psychiatry 2009, 194(6):535-540.
24. Murray F., Hutson P.H. Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists. European Journal of Pharmacology 2007, 569(1):41-47.
25. Stoltenberg S.F., Twitchell G.R., Hanna G.L., Cook E.H., Fitzgerald H.E., Zucker R.A., Little K.Y. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. American Journal of Medical Genetics 2002, 114(2):230-234.
26. Yu Y.W., Tsai S.J., Chen T.J., Lin C.H., Hong C.J. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Molecular Psychiatry 2002, 7(10):1115-1119.